2021 ICD-10-CM Code D02.2

Carcinoma in situ of bronchus and lung

Version 2021

Not Valid for Submission

D02.2 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of carcinoma in situ of bronchus and lung. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic bronchiogenic, bronchogenic (lung) ; Neoplasm, neoplastic bronchiole ; Neoplasm, neoplastic bronchus ; Neoplasm, neoplastic bronchus carina ; Neoplasm, neoplastic bronchus lower lobe of lung ; Neoplasm, neoplastic bronchus main ; Neoplasm, neoplastic bronchus upper lobe of lung ; etc

ICD-10:D02.2
Short Description:Carcinoma in situ of bronchus and lung
Long Description:Carcinoma in situ of bronchus and lung

Code Classification

Specific Coding for Carcinoma in situ of bronchus and lung

Non-specific codes like D02.2 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for carcinoma in situ of bronchus and lung:

  • BILLABLE CODE - Use D02.20 for Carcinoma in situ of unspecified bronchus and lung
  • BILLABLE CODE - Use D02.21 for Carcinoma in situ of right bronchus and lung
  • BILLABLE CODE - Use D02.22 for Carcinoma in situ of left bronchus and lung

Table of Neoplasms

The code D02.2 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bronchiogenic, bronchogenic (lung)
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchiole
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »carina
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »lower lobe of lung
C34.3C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »main
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »bronchus
    »upper lobe of lung
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »carina (bronchus)
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »hilus of lung
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lingula, lung
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »azygos lobe
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »carina
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »hilus
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »linqula
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »lobe NEC
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »lower lobe
C34.3C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »main bronchus
C34.0C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »lung
    »upper lobe
C34.1C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »pulmonary [See Also: Neoplasm, lung]
C34.9C78.0D02.2D14.3D38.1D49.1
»Neoplasm, neoplastic
  »subpleural
C34.9C78.0D02.2D14.3D38.1D49.1

Information for Patients


Lung Cancer

Also called: Bronchogenic carcinoma

Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.

Common symptoms of lung cancer include

Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)